BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lee CH, Kim JH, Lee SW. Prospects for nucleic acid-based therapeutics against hepatitis C virus. World J Gastroenterol 2013; 19(47): 8949-8962 [PMID: 24379620 DOI: 10.3748/wjg.v19.i47.8949]
URL: https://www.wjgnet.com/1007-9327/full/v19/i47/8949.htm
Number Citing Articles
1
Alba Fernández-Sanlés, Beatriz Berzal-Herranz, Rodrigo González-Matamala, Pablo Ríos-Marco, Cristina Romero-López, Alfredo Berzal-Herranz. RNA Aptamers as Molecular Tools to Study the Functionality of the Hepatitis C Virus CRE RegionMolecules 2015; 20(9): 16030 doi: 10.3390/molecules200916030
2
E. Crouchet, R. Saad, C. Affolter-Zbaraszczuk, J. Ogier, T. F. Baumert, C. Schuster, F. Meyer. Composite vector formulation for multiple siRNA delivery as a host targeting antiviral in a cell culture model of hepatitis C virus (HCV) infectionJournal of Materials Chemistry B 2017; 5(4): 858 doi: 10.1039/C6TB01718E
3
Anandita Agarwala, Peter Jones, Vijay Nambi. The Role of Antisense Oligonucleotide Therapy in Patients with Familial Hypercholesterolemia: Risks, Benefits, and Management RecommendationsCurrent Atherosclerosis Reports 2015; 17(1) doi: 10.1007/s11883-014-0467-4
4
Hirofumi Morihara, Tsuyoshi Yamamoto, Harunori Oiwa, Kota Tonegawa, Daisuke Tsuchiyama, Ikki Kawakatsu, Masanori Obana, Makiko Maeda, Tomomi Mohri, Satoshi Obika, Yasushi Fujio, Hiroyuki Nakayama. Phospholamban Inhibition by a Single Dose of Locked Nucleic Acid Antisense Oligonucleotide Improves Cardiac Contractility in Pressure Overload-Induced Systolic Dysfunction in MiceJournal of Cardiovascular Pharmacology and Therapeutics 2017; 22(3): 273 doi: 10.1177/1074248416676392
5
Tae-Hyeong Kim, Seong-Wook Lee. Aptamers for Anti-Viral Therapeutics and DiagnosticsInternational Journal of Molecular Sciences 2021; 22(8): 4168 doi: 10.3390/ijms22084168
6
Chang Ho Lee, Seung Ryul Han, Seong-Wook Lee. Therapeutic Applications of Aptamer-Based RiboswitchesNucleic Acid Therapeutics 2016; 26(1): 44 doi: 10.1089/nat.2015.0570
7
Chang Ho Lee, Ji Hyun Kim, Seong-Wook Lee. The role of microRNAs in Hepatitis C Virus replication and related liver diseasesJournal of Microbiology 2014; 52(6): 445 doi: 10.1007/s12275-014-4267-x
8
Patrick Arbuthnot. Gene Therapy for Viral Infections2015; : 191 doi: 10.1016/B978-0-12-410518-8.00007-7
9
Stefan Mockenhaupt, Stefanie Grosse, Daniel Rupp, Ralf Bartenschlager, Dirk Grimm. Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoysProceedings of the National Academy of Sciences 2015; 112(30): E4007 doi: 10.1073/pnas.1510476112
10
Peng Li, Bow Ho, Jeak Ling Ding. Future Perspectives on New Approaches in Pathogen DetectionBiomedical Science Letters 2015; 21(4): 165 doi: 10.15616/BSL.2015.21.4.165
11
Víctor González, M. Martín, Gerónimo Fernández, Ana García-Sacristán. Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human VirusesPharmaceuticals 2016; 9(4): 78 doi: 10.3390/ph9040078
12
Kei Xian Tan, Sharadwata Pan, Jaison Jeevanandam, Michael K. Danquah. Cardiovascular therapies utilizing targeted delivery of nanomedicines and aptamersInternational Journal of Pharmaceutics 2019; 558: 413 doi: 10.1016/j.ijpharm.2019.01.023